New Bispectral Index Monitoring (BIS) Algorithm Significantly Improves Detection of Deep Sedation During Elective Endoscopy with Meperidine/Midazolam John Vargo, Gregory Zuccaro, Sandeep Patel, John Dumot, Darwin Conwell, Patricia Trolli Background: Deep sedation during endoscopy theoretically increases the risk of cardiopulmonary complications. According to the American Society for Anesthesiology (ASA) guidelines endorsed by the ASGE, deep sedation requires the presence of personnel dedicated to the continuous and uninterrupted monitoring of the patient’s physiologic parameters. BIS, an objective measure of frontal cortex activity, is currently used for monitoring levels of sedation during surgical procedures. Recently, a novel version (v) of the BIS-XP algorithm (v 4.1 Aspect Medical Systems, Newton, MA) has been developed to improve the measurement of sedation. Aims: To compare the performance of the newest BIS-XP algorithm with its predecessor (v 4.1 and v 4.0) in their ability to measure deep sedation with meperidine and midazolam (M/M) during elective endoscopy. Methods: Healthy (ASA Class I and II) patients undergoing elective outpatient EGD, EUS, ERCP, and colonoscopy were enrolled. The BIS index (v 4.0 and v 4.1) and the Modified Observer’s Assessment Alertness Sedation Scale (MOAAS) were simultaneously recorded q 3 minutes throughout the procedure. The BIS index is a 100 point scale (100 Z awake, 0 Z isoelectric) and the MOAAS is a 5 point ordinal scale (5 Z awake, 1 Z no response to mild physical stimulation). The ability to correctly measure episodes of deep sedation (MOAAS % 2) were compared using an ROC analysis. The C statistic (C) was used to determine the area under the curve (AUC) for both algorithms. Results: 73 patients (21 EGD, 13 EUS, 19 ERCP, 20 colonoscopy) were analyzed. No significant differences in gender or age were noted among the four groups. Both BIS algorithms were significant predictors of deep sedation (MOASS 1 and 2). However, the AUC for BIS v 4.1 (C Z 0.74, 95% CI: 0.70 – 0.780), was significantly higher than BIS v 4.0 (C Z 0.68, 95% CI: 0.63 – 0.73). Conclusion: The newer BIS (v 4.1) is superior to its BIS-XP predecessor in the measurement of deep sedation. BIS (v 4.1) has the promise of providing a real-time, continuous assessment of deeper levels of sedation when using meperidine and a midazolam.